Allyson Whyte Nowak

IAM Research

The Patent 1000 focuses exclusively on patent practice and has firmly established itself as the definitive 'go-to' resource for those seeking world-class legal patent expertise.

Silver - Individuals: litigation

A comprehensive offering, widespread domestic coverage – it has outposts in Calgary, Montreal, Ottawa, Quebec, Toronto and Vancouver – and a mighty international network make Norton Rose Fulbright more than just an able running mate to some of the world’s most prominent life sciences and pharmaceutical companies. This year has seen it battle it out in some headline-grabbing cases – for instance, it acted for Pfizer in the first action to go to trial under the PM(NOC) Regulations and represented Novo Nordisk in the first patent infringement action commenced under Section 8.2 of the regulations. Taking the lead on the former was Mark Davis, a “sharp, first-class litigator who is relentless in advocating for his clients. He is personable, easy to work with and gives practical advice”. Allyson Whyte Nowak and Amy Grenon also receive glowing feedback: “Allyson provides excellent advice, strategic counsel and solutions that are very thoughtful and aligned with a company’s overall objectives, while maintaining an outstanding level of client service.” “Amy is a fantastic litigator – she effectively and persuasively communicates the essence of complex technologies to the court. Her presentations are smooth and exude confidence, and she remains steady and focused during objections too. To top it off, she can answer any question at a moment’s notice, thanks to her instant recall of every case she works on.” Bringing great regulatory insight to the table, meanwhile, is Brian Daley, who prevailed for I-MED Pharma against TearLab Corporation. IAM Patent 1000 newcomer Kristin Wall makes her debut in the guide on the back of stellar work for GlaxoSmithKline: she fought the corner of the pharmaceutical giant in the first court challenge under Canada’s newly enacted Certificate of Supplementary Protection Regulations. Over on the prosecution wing, Sébastien Clark and Maya Medeiros are the main attractions. A highly regarded scientific adviser in contentious proceedings, Clark is also a superb drafter and strategic counsellor – as evidenced by his work for Bombardier, which covers its entire global portfolio. Of Medeiros, one patron enthuses: “She truly goes above and beyond to support us in research and collaboration products. Her legal talent and client-centricity are exceptional: she is committed to understanding our business, technology and objectives, and always bears them in mind when giving advice.” National IP chair Jung-Kay Chiu is an extremely versatile operator who has recently been working with Johnson & Johnson on its patent strategy.

Get unlimited access to all IAM content